Clinical Trials Directory

Trials / Completed

CompletedNCT01491620

Study of the 532 nm KTP Laser for the Treatment of Poikiloderma of Civatte

A Single-Center Prospective, Open-Label Study of the Excel V 532 nm KTP Laser for the Treatment of Poikiloderma of Civatte

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Cutera Inc. · Industry
Sex
All
Age
35 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate the safety and efficacy of the Excel V 532 nm KTP laser for the treatment of dyschromia of the neck and/or chest (poikiloderma of Civatte).

Conditions

Interventions

TypeNameDescription
DEVICE532 nm KTP laserLaser treatment sessions on the neck and/or chest

Timeline

Start date
2011-11-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2011-12-14
Last updated
2022-10-28
Results posted
2022-10-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01491620. Inclusion in this directory is not an endorsement.

Study of the 532 nm KTP Laser for the Treatment of Poikiloderma of Civatte (NCT01491620) · Clinical Trials Directory